ALK and neoplasm: EML4-ALK mutation generates the loss of the extracellular domain of the ALK protein, leading to constitutive phosphorylation of the intracellular tyrosine kinase domain trapped into the cytosol, and to the activation of oncogenic signaling pathways such as cell survival, proliferation and tumor growth [9].